Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Globus Medical, which has a market cap of $11.9bn, will buy all Nevro ... stimulator systems, for example, gained access to a wider market after winning FDA approval for non-surgical back pain ...

“We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering ...